| mRNA |
L-685458 |
CCLE |
pan-cancer |
AAC |
0.0032 |
0.9 |
| mRNA |
ELCPK |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
| mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
0.002 |
1 |
| mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
1 |
| mRNA |
Cytarabine |
FIMM |
pan-cancer |
AAC |
0.0093 |
1 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0019 |
1 |
| mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0019 |
1 |
| mRNA |
Vorinostat |
FIMM |
pan-cancer |
AAC |
0.0084 |
1 |
| mRNA |
HC-067047 |
CTRPv2 |
pan-cancer |
AAC |
-0.002 |
1 |
| mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
1 |